Advertisement
Osimertinib is more effective than platinum-pemetrexed therapy in patients with T790M-positive advanced non-small-cell lung cancer whose disease has progressed during first-line epidermal growth factor receptor tyrosine kinase inhibitor treatment

Osimertinib Bests Platinum-Pemetrexed in T790M+ NSCLC

0
Significantly longer duration of progression-free survival with osimertinib vs platinum-pemetrexed
A single dose of an experimental gene therapy may benefit patients with hemophilia B

ASH: Single Dose of Gene Therapy Effective in Hemophilia B

0
Small, preliminary trial suggests it may free hemophilia B patients from transfusions
A vaccine made from patient-derived acute myeloid leukemia cells and dendritic cells can dramatically increase the chance of long-term survival against acute myeloid leukemia

Personalized Vaccine Effective Against Acute Myeloid Leukemia

0
Made by combining immune cells, cancer cells, it's kept some patients in remission for nearly five years

American Society of Hematology, Dec. 3-6

0
The 58th American Society of Hematology Annual Meeting & Exposition The annual meeting of the American Society of Hematology was held from Dec....
When breast cancer spreads to the brain

SABCS: Molecular Changes Occur When Breast CA Spreads to Brain

0
Finding might lead to better treatment, researchers say
The prevalence of disability is 2.7 percent among medical students at U.S. allopathic medical schools

Prevalence of Disability 2.7 Percent at U.S. Medical Schools

0
Most common disability is ADHD followed by learning disabilities and psychological disabilities
Specific learning interventions may improve emotional well-being among medical students

Learning Interventions Can Improve Med Student Well-Being

0
Environmental interventions such as pass/fail grading system, mental health programs beneficial
Cancer cases rose 33 percent worldwide in the past 10 years

Number of Cancer Cases, Deaths Up Globally

0
Researchers cite population aging and growth
Older breast cancer survivors taking letrozole for more than the recommended five years may not live longer; however

SABCS: No Survival Benefit Seen for Letrozole Beyond Five Years

0
Study found women who continued with letrozole did experience other benefits, however
According to a presentation at the annual meeting of the American Society of Hematology

ASH: Synthetic Blood Cell Passes Proof-of-Concept Testing

0
Synthetic product made from purified human hemoglobin proteins coated with a synthetic polymer